---
title: "Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292356746.md"
description: "On July 10, 2026, Context Therapeutics Inc. revealed that it has provided a non-qualified stock option award to acquire 146,000 shares of its common stock to a newly hired employee. The company, listed as (Nasdaq: CNTX), specializes in developing T cell engaging bispecific antibodies for solid tumors. This stock option award was given as an inducement for the individual to accept employment with Context."
datetime: "2026-07-10T20:22:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292356746.md)
  - [en](https://longbridge.com/en/news/292356746.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292356746.md)
generator: "portal-rs"
---

# Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

On July 10, 2026, Context Therapeutics Inc. revealed that it has provided a non-qualified stock option award to acquire 146,000 shares of its common stock to a newly hired employee. The company, listed as (Nasdaq: CNTX), specializes in developing T cell engaging bispecific antibodies for solid tumors. This stock option award was given as an inducement for the individual to accept employment with Context.

### Related Stocks

- [CNTX.US](https://longbridge.com/en/quote/CNTX.US.md)

## Related News & Research

- [Context Therapeutics doses first patient in Phase 1 trial of CT-202 bispecific antibody](https://longbridge.com/en/news/298449932.md)
- [Faron Pharmaceuticals to host investor R&D Day on bexmarilimab program](https://longbridge.com/en/news/298544684.md)
- [Alpha-9 Oncology doses first patient in Phase 1 trial of GRPR-targeted radiotherapeutics](https://longbridge.com/en/news/298604842.md)
- [Dogwood Announces Completion of Enrollment in Ongoing Halneuron® Phase 2b Trial | DWTX Stock News](https://longbridge.com/en/news/298920980.md)
- [Immunocore Completes Enrollment in Phase 3 Melanoma Trial](https://longbridge.com/en/news/298913537.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**